Trials / Completed
CompletedNCT02701127
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single center, randomized, single-blind, placebo-controlled study to evaluate the safety and biochemical effects of niacinamide on metabolic parameters of the kidney in patients undergoing cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral niacinamide, 1 gram daily | |
| DRUG | Oral niacinamide, 3 gram daily | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-02-01
- Completion
- 2017-07-01
- First posted
- 2016-03-08
- Last updated
- 2018-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02701127. Inclusion in this directory is not an endorsement.